Patch for at-home use detects sleep apnea

Researchers have developed a wearable patch to diagnose obstructive sleep apnea at all severity levels. Researchers, who published findings in Sleep, aimed to create a cost-effective, lightweight wearable to monitor patients without disrupting sleep patterns.

Current home sleep monitors often disrupt patients, making them less accurate. The SomnaPatch weighs less than an ounce and can be easily set up by patients in their home.

Able to record nasal pressure, blood oxygen saturation, pulse rate, respiratory effort, sleep time and body position, the SomnaPatch was compared in effectiveness with standard in-lab polysomnography. Some 174 patients were recorded for simultaneously polysomnography and patch recordings and then auto-scored by Somnolyzer software.

Results showed the patch and lab polysomnography had a total rate of clinical agreement at 87.4 percent, with a 95 percent confidence interval of 81.4 percent to 91.9 percent. Additionally, home usability rates found 38 out of 39 users were successful in activating the patch and recording four hours of sleep data.

"Our study provided clinical validation of a new wearable device for diagnosing sleep apnea," said principal investigator Maria Merchant, PhD, CEO of Somnarus. "It was most surprising to us how well this inexpensive miniature device performed in comparison with in-lab sleep studies. Most home sleep diagnostic devices are difficult for patients to use and are disruptive to patient's sleep. Our study showed that this wearable home sleep monitor is very comfortable, easy to use and does not negatively affect sleep."

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”